Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovam Battista Rini

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
The American Journal of the Medical Sciences|August 16, 2006
Statins, fracture risk, and bone remodeling: What is true?Manfredi Rizzo, Giovam Battista Rini
Archives of Medical Science : AMS|February 1, 2012
Ezetimibe, cardiovascular risk and atherogenic dyslipidaemiaManfredi Rizzo, Giovam Battista Rini
Advances in Therapy|July 31, 2007
Effects of statins, fibrates, rosuvastatin, and ezetimibe beyond cholesterol: the modulation of LDL size and subclasses in high-risk patientsManfredi Rizzo, Giovam Battista Rini, Kaspar Berneis
American Journal of Obstetrics and Gynecology|January 2, 2008
How should we manage atherogenic dyslipidemia in women with polycystic ovary syndrome?Manfredi Rizzo, Kaspar Berneis, Enrico Carmina, et al.
Acta Diabetologica|October 18, 2008
The therapeutic modulation of atherogenic dyslipidemia and inflammatory markers in the metabolic syndrome: what is the clinical relevance?Manfredi Rizzo, Ali A Rizvi, Giovam Battista Rini, et al.
Atherosclerosis|November 26, 2008
The effects of ezetimibe on LDL-cholesterol: quantitative or qualitative changes?Manfredi Rizzo, Giovam Battista Rini, Giatgen A Spinas, et al.
International Journal of Cardiology|March 20, 2009
Is diabetes the cost to pay for a greater cardiovascular prevention?Manfredi Rizzo, Giatgen A Spinas, Giovam Battista Rini, et al.
Fertility and Sterility|November 4, 2008
Long-term consequences of polycystic ovary syndrome on cardiovascular riskManfredi Rizzo, Kaspar Berneis, Giatgen Spinas, et al.
Clinical Cases in Mineral and Bone Metabolism : the Official Journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases|October 7, 2014
Correlation between osteoporosis and cardiovascular diseaseDelia Sprini, Giovam Battista Rini, Laura Di Stefano, et al.
Fertility and Sterility|April 3, 2009
High prevalence of polycystic ovary syndrome in women with mild hirsutism and no other significant clinical symptomsGaetana Di Fede, Pasquale Mansueto, Ilenia Pepe, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
The American Journal of the Medical Sciences|August 16, 2006
Statins, fracture risk, and bone remodeling: What is true?Manfredi Rizzo, Giovam Battista Rini
Archives of Medical Science : AMS|February 1, 2012
Ezetimibe, cardiovascular risk and atherogenic dyslipidaemiaManfredi Rizzo, Giovam Battista Rini
Advances in Therapy|July 31, 2007
Effects of statins, fibrates, rosuvastatin, and ezetimibe beyond cholesterol: the modulation of LDL size and subclasses in high-risk patientsManfredi Rizzo, Giovam Battista Rini, Kaspar Berneis
American Journal of Obstetrics and Gynecology|January 2, 2008
How should we manage atherogenic dyslipidemia in women with polycystic ovary syndrome?Manfredi Rizzo, Kaspar Berneis, Enrico Carmina, et al.
Acta Diabetologica|October 18, 2008
The therapeutic modulation of atherogenic dyslipidemia and inflammatory markers in the metabolic syndrome: what is the clinical relevance?Manfredi Rizzo, Ali A Rizvi, Giovam Battista Rini, et al.
Atherosclerosis|November 26, 2008
The effects of ezetimibe on LDL-cholesterol: quantitative or qualitative changes?Manfredi Rizzo, Giovam Battista Rini, Giatgen A Spinas, et al.
International Journal of Cardiology|March 20, 2009
Is diabetes the cost to pay for a greater cardiovascular prevention?Manfredi Rizzo, Giatgen A Spinas, Giovam Battista Rini, et al.
Fertility and Sterility|November 4, 2008
Long-term consequences of polycystic ovary syndrome on cardiovascular riskManfredi Rizzo, Kaspar Berneis, Giatgen Spinas, et al.
Clinical Cases in Mineral and Bone Metabolism : the Official Journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases|October 7, 2014
Correlation between osteoporosis and cardiovascular diseaseDelia Sprini, Giovam Battista Rini, Laura Di Stefano, et al.
Fertility and Sterility|April 3, 2009
High prevalence of polycystic ovary syndrome in women with mild hirsutism and no other significant clinical symptomsGaetana Di Fede, Pasquale Mansueto, Ilenia Pepe, et al.
Pageof 5